[Elsevier] Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a ... |
|
This post will be closed automatically in 2026-11-04 02:50
Reward50points
|
10
Recent advances in molecularly imprinted polymers for the detection of microorganisms
10
The price of going green: Multi-objective optimization in the energy equity space
50
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a ...
10
Advancing biomedical waste classification through a hybrid ensemble of deep Learning, reinforcement Learning, and differential evolution algorithms
10
Selecting climate mitigation indicators for tracking municipal climate targets and goals
